Myocarditis after BNT162b2 Vaccination in Israeli Adolescents
Myocarditis after BNT162b2 Vaccination in Israeli Adolescents
About this item
Full title
Author / Creator
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
In an active surveillance program from the Israeli Ministry of Health, estimates of myocarditis risk in the 21 days after a first and second dose of vaccine were, respectively, 0.56 per 100,000 and 8.09 per 100,000 among male recipients and 0 per 100,000 and 0.69 per 100,000 among female recipients.
Alternative Titles
Full title
Myocarditis after BNT162b2 Vaccination in Israeli Adolescents
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8823652
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8823652
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMc2116999
